慧智 (6615)
慧智 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$30.55M, up 1.8% from a year earlier. EPS over the last four quarters totals NT$0.66.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2018-01-22
- Founded
- 2012-06-15
- Paid-in capital
- NT$215.93M
- Common shares issued
- 21,593,400
- Legal name
- 慧智基因股份有限公司
- Website
- http://www.sofivagenomics.com.tw
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$30.55M | +0.6% | +1.8% |
| 2026-08 | NT$30.37M | -9.8% | -2.4% |
Year to date: -1.8% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.25 |
| 2026 Q1 | 0.67 |
| 2025 Q4 | -0.21 |
| 2025 Q3 | -0.05 |
| 2025 Q2 | -0.02 |
| 2025 Q1 | -0.15 |
| 2024 Q4 | -0.25 |
| 2024 Q3 | 0.08 |
Last four quarters: NT$0.66
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 3,167 | 2.8% |
| 1,000–5,000 shares | 1,825 | 15.6% |
| 5,001–10,000 shares | 131 | 4.7% |
| 10,001–15,000 shares | 45 | 2.7% |
| 15,001–20,000 shares | 25 | 2.1% |
| 20,001–30,000 shares | 36 | 4.5% |
| 30,001–40,000 shares | 11 | 1.8% |
| 40,001–50,000 shares | 11 | 2.4% |
| 50,001–100,000 shares | 16 | 5.5% |
| 100,001–200,000 shares | 7 | 4.1% |
| 200,001–400,000 shares | 2 | 2.3% |
| 400,001–600,000 shares | 6 | 12.8% |
| 600,001–800,000 shares | 1 | 2.8% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 5 | 35.9% |
TDCC data for 2026-10-16: 5 holders own more than 1,000 lots (35.9% of shares), and 3,167 hold less than one lot (2.8%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 0 | 0 | 0 | 0 |
| 2026-10-13 | 0 | 0 | 0 | 0 |
| 2026-10-08 | -1 | 0 | 0 | -1 |
| 2026-10-07 | -6 | 0 | 0 | -6 |
| 2026-10-06 | -1 | 0 | 0 | -1 |
| 2026-10-05 | 15 | 0 | 0 | 15 |
| 2026-10-02 | 1 | 0 | 0 | 1 |
| 2026-10-01 | 2 | 0 | 0 | 2 |
| 2026-09-30 | 1 | 0 | 0 | 1 |
| 2026-09-29 | 1 | 0 | 0 | 1 |
| 2026-09-23 | 3 | 0 | 0 | 3 |
| 2026-09-17 | 1 | 0 | 0 | 1 |
| 2026-09-16 | -1 | 0 | 0 | -1 |
| 2026-09-10 | 2 | 0 | 0 | 2 |
| 2026-09-09 | 1 | 0 | 0 | 1 |
| 2026-09-08 | 1 | 0 | 0 | 1 |
| 2026-09-07 | -4 | 0 | 0 | -4 |
| 2026-09-01 | -1 | 0 | 0 | -1 |
| 2026-08-28 | 4 | 0 | 0 | 4 |
| 2026-08-27 | -1 | 0 | 0 | -1 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 17 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$33.15 (2026-10-19); 52-week range NT$28.90–40.00.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.